Why BioNTech Stock Soared Today
BioNTech (NASDAQ: BNTX), one of the companies made famous for its role developing vaccines with (NYSE: PFE) during the COVID-19 pandemic, soared 20.2% through 12:50 p.m. Monday on news entirely unrelated to COVID.
The German biotech announced this morning it is partnering with pharmaceuticals giant Bristol Myers Squibb (NYSE: BMY) to "co-develop and co-commercialize" BioNTech's drug candidate BNT327 as an immunotherapy against multiple kinds of cancer.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
21,62 €
-0,69 %
Eine Tendenz zu Buy-Einschätzungen bei Pfizer Inc., überwiegend gegenüber Sell-Einschätzungen.
Für Pfizer Inc. sieht die Community ein Kursziel von 29 €, was eine erhebliche Steigerung um über 20% gegenüber dem aktuellen Kurs von 21.62 € bedeutet.
